Does concentric left ventricular remodeling occur in ischemic heart disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Concentric LV Remodeling Occur in Ischemic Heart Disease?

Yes, concentric left ventricular remodeling is directly associated with ischemic heart disease and represents a late-stage response to myocardial infarction and coronary artery disease. 1

Definition and Pathophysiology

Concentric LV remodeling is characterized by:

  • Normal or small LV cavity size 1
  • Increased LV wall thickness 1
  • Normal left ventricular mass (LVM ≤115 g/m² in men or ≤95 g/m² in women) 2
  • Relative wall thickness (RWT) ≥0.42 2

This geometric pattern can be caused by chronic pressure overload, volume overload, or myocardial infarction, and is most commonly associated with coronary artery disease. 1

Evidence Linking Concentric Remodeling to Ischemic Disease

Direct Association with CAD

The European Association of Cardiovascular Imaging guidelines explicitly state that concentric remodeling is most commonly associated with coronary artery disease, though it also occurs with longstanding hypertension. 1 This pattern represents local LV remodeling with apical and posterior displacement of papillary muscles in ischemic disease. 1

Quantitative Relationship

Patients with more extensive coronary plaque burden (>4 segments) demonstrate significantly higher LVM and are twice as likely to have concentric remodeling compared to those without CAD. 3 Specifically:

  • Each 20g increase in LVM correlates with 0.27-0.29 additional segments of coronary plaque 3
  • Concentric remodeling patients have 1.1-1.3 more segments of plaque than those with normal geometry 3

Mechanism in Ischemic Heart Disease

In chronic ischemic disease, concentric remodeling develops through local LV remodeling that leads to:

  • Excess valvular tenting 1
  • Loss of systolic annular contraction 1
  • Papillary muscle displacement with leaflet tethering 1

This process is distinct from the pressure-overload mechanism seen in hypertension. 1

Clinical Implications and Prognosis

Prognostic Significance

The prognostic implications differ based on whether left ventricular hypertrophy is present:

In patients with stable coronary artery disease without LVH, concentric remodeling alone does not independently predict adverse cardiovascular events, heart failure hospitalization, or cardiovascular death. 4 This contrasts with concentric and eccentric LVH, which do predict worse outcomes. 4, 5

However, when concentric LVH is present in patients with CAD, it confers the highest risk of both all-cause and cardiac mortality. 5

Distinction from Hypertensive Remodeling

While concentric remodeling is also associated with longstanding hypertension, the mechanism differs from ischemic disease. 1 In hypertension, it represents a response to chronic pressure overload, whereas in ischemic disease it results from post-infarction remodeling and papillary muscle displacement. 1

Common Pitfalls and Caveats

Do not assume all concentric remodeling in CAD patients carries the same prognosis as concentric LVH—the presence or absence of increased LV mass is the critical distinguishing factor for risk stratification. 4, 5

The conventional concept that hypertension leads to concentric hypertrophy followed by chamber dilation has been challenged—concentric hypertrophy is actually less common than eccentric hypertrophy even in hypertensive subjects. 6

When evaluating patients with both CAD and concentric remodeling, assess for ischemic mitral regurgitation, as the geometric changes predispose to valvular dysfunction through papillary muscle displacement. 1

Related Questions

Is concentric left ventricular (LV) remodeling the same as hypertrophy in a patient with a history of hypertension?
In a patient with ischemic heart disease and concentric left ventricular (LV) remodeling, does this cause moderate pulmonary hypertension?
Please explain in simple terms the echo results showing moderate concentric left‑ventricular hypertrophy, left‑ventricular ejection fraction 55‑60 %, mild ascending aortic dilation (3.9 cm), severe pulmonary artery dilation (5.4 cm), and the recommendation for NYHA heart‑failure staging.
What is the recommended management for a patient with a history of Coronary Artery Disease (CAD), Myocardial Infarction (MI), and reduced Left Ventricular Ejection Fraction (LVEF) of 55-60%, presenting with symptoms of shortness of breath, palpitations, and chest pressure upon exertion, and echocardiogram results showing normal left ventricular size and systolic function, concentric remodeling, mildly increased Left Ventricular (LV) wall thickness, mild aortic regurgitation, and a mildly dilated aortic root?
What is the ansa cervicalis, its anatomical composition, the muscles it innervates, and its clinical significance?
In a child with bronchial asthma whose chest X‑ray taken between exacerbations is normal, what is the most appropriate information to give the parents?
How should thyroid storm be diagnosed and managed in an adult presenting with acute severe hyperthyroid symptoms (fever >38 °C, tachycardia >130 bpm, altered mental status, gastrointestinal upset, or heart failure) and a Burch‑Wartofsky point scale score ≥45 with suppressed thyroid‑stimulating hormone and markedly elevated free thyroxine and/or triiodothyronine?
How is Kawasaki disease diagnosed in a child under five years old presenting with fever for at least five days and possible clinical features?
What folic acid dose should a woman planning pregnancy take, and what dose is recommended for high‑risk risk factors?
In a patient with ischemic heart disease and concentric left ventricular (LV) remodeling, does this cause moderate pulmonary hypertension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.